FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, molecular biology and medicine. Presented the use of at least one miR-124 microRNA as a biomarker of a viral infection, or the effectiveness of the therapeutic treatment of the above viral infection.
EFFECT: treating said viral infection.
23 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKERS AND APPLICATIONS IN TREATING VIRAL INFECTIONS, INFLAMMATIONS OR CANCER | 2019 |
|
RU2820481C2 |
| QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2015 |
|
RU2760686C2 |
| QUINOLINE DERIVATIVES FOR USE IN TREATMENT OR PREVENTION OF CANCER | 2019 |
|
RU2811417C2 |
| DETERMINING MICRORNA IN PLASMA FOR DETECTING COLORECTAL CANCER IN ITS EARLY STAGES | 2012 |
|
RU2662975C1 |
| QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
| MIRNA DEFINITION PLASMA FOR DETECTION OF EARLY STAGES OF COLORECTAL CANCER | 2012 |
|
RU2611189C2 |
| BIOMARKERS OF TRAUMATIC BRAIN INJURY | 2017 |
|
RU2771757C2 |
| MICRO-RNA-BIOMARKERS INDICATING ALZHEIMER'S DISEASE | 2012 |
|
RU2639509C2 |
| METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
| METHODS FOR CLASSIFYING PATIENTS WITH SOLID CANCER | 2017 |
|
RU2745730C2 |
